Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 2,220

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

The epidemiology of glioma in adults: a "state of the science" review

Open access
Ostrom, Q. T., Bauchet, L., Davis, F. G., Deltour, I., Fisher, J. L., Langer, C. E., Pekmezci, M., Schwartzbaum, J. A., Turner, M. C., Walsh, K. M., Wrensch, M. R., Barnholtz-Sloan, J. S.·2014·Neuro-Oncology
DOI 10.1093/neuonc/nou087
Open this paper in CoChat — free account

Abstract

Gliomas are the most common primary intracranial tumor, representing 81% of malignant brain tumors. Although relatively rare, they cause significant mortality and morbidity. Glioblastoma, the most common glioma histology (∼45% of all gliomas), has a 5-year relative survival of ∼5%. A small portion of these tumors are caused by Mendelian disorders, including neurofibromatosis, tuberous sclerosis, and Li-Fraumeni syndrome. Genomic analyses of glioma have also produced new evidence about risk and prognosis. Recently discovered biomarkers that indicate improved survival include O⁶-methylguanine-DNA methyltransferase methylation, isocitrate dehydrogenase mutation, and a glioma cytosine-phosphate-guanine island methylator phenotype. Genome-wide association studies have identified heritable risk alleles within 7 genes that are associated with increased risk of glioma. Many risk factors have been examined as potential contributors to glioma risk. Most significantly, these include an increase in risk by exposure to ionizing radiation and a decrease in risk by history of allergies or atopic disease(s). The potential influence of occupational exposures and cellular phones has also been examined, with inconclusive results. We provide a “state of the science” review of current research into causes and risk factors for gliomas in adults.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/neuonc/nou087

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 146

  1. 2013, Neuro-Oncology, 15, ii1, 10.1093/neuonc/not151 · DOI · Paper page
  2. Louis, 2007, Acta neuropathologica, 114, 97, 10.1007/s00401-007-0243-4 · DOI · Paper page
  3. 2012, Asian Pacific journal of cancer prevention : APJCP, 13, 5857, 10.7314/APJCP.2012.13.11.5857 · DOI
  4. 2009, Neuro-Oncology, 11, 403, 10.1215/15228517-2008-097 · DOI
  5. Crocetti, 2012, European journal of cancer (Oxford, England : 1990), 48, 1532, 10.1016/j.ejca.2011.12.013 · DOI · Paper page
  6. Lee, 2010, 48, 145, 10.3340/jkns.2010.48.2.145 · DOI
  7. Deltour, 2012, Epidemiology (Cambridge, Mass.), 23, 301, 10.1097/EDE.0b013e3182448295 · DOI · Paper page
  8. Dobes, 2011, 2, 176, 10.4103/2152-7806.90696 · DOI
  9. Wohrer, 2009, Journal of neuro-oncology, 95, 401, 10.1007/s11060-009-9938-9 · DOI
  10. 2013, Journal of neuro-oncology, 112, 241, 10.1007/s11060-013-1054-1 · DOI
  11. 2007, Neuro-Oncology, 9, 319, 10.1215/15228517-2007-016 · DOI · Paper page
  12. Gousias, 2009, Neuroepidemiology, 33, 89, 10.1159/000222090 · DOI
  13. Dubrow, 2011, BMC cancer [electronic resource], 11, 325, 10.1186/1471-2407-11-325 · DOI
  14. 2009, Neuro-Oncology, 11, 311, 10.1215/15228517-2008-105 · DOI
  15. 2012, BMJ, 344, e1147, 10.1136/bmj.e1147 · DOI · Paper page
  16. Chitnavis, 2001, Journal of neurosurgery, 95, 190, 10.3171/jns.2001.95.2.0190 · DOI · Paper page
  17. 2010, Neuro-Oncology, 12, 725, 10.1093/neuonc/noq030 · DOI
  18. Sant, 2012, International journal of cancer. Journal international du cancer, 131, 173, 10.1002/ijc.26335 · DOI
  19. Tseng, 2006, Journal of neurosurgery, 105, 297
  20. Jung, 2012, Journal of neuro-oncology, 109, 301, 10.1007/s11060-012-0893-5 · DOI
  21. Jakola, 2012, JAMA, 308, 1881, 10.1001/jama.2012.12807 · DOI · Paper page
  22. Stupp, 2007, Journal of Clinical Oncology, 25, 4127, 10.1200/JCO.2007.11.8554 · DOI
  23. Koshy, 2012, Journal of neuro-oncology, 107, 207, 10.1007/s11060-011-0738-7 · DOI · Paper page
  24. 2012, Cancer, 118, 2163, 10.1002/cncr.26494 · DOI
  25. 2012, Cancer, 118, 5608, 10.1002/cncr.27590 · DOI
  26. Ohgaki, 2007, American Journal Of Pathology, 170, 1445, 10.2353/ajpath.2007.070011 · DOI · Paper page
  27. Noushmehr, 2010, Cancer cell, 17, 510, 10.1016/j.ccr.2010.03.017 · DOI · Paper page
  28. Jiao, 2012, 3, 709, 10.18632/oncotarget.588 · DOI · Paper page
  29. Smith, 2000, Journal of Clinical Oncology, 18, 636, 10.1200/JCO.2000.18.3.636 · DOI · Paper page
  30. 2010, OGPL Neurology, 74, 1886, 10.1212/WNL.0b013e3181e1cf3a · DOI · Paper page
  31. 2011, Science, 333, 1453, 10.1126/science.1210557 · DOI · Paper page
  32. Liu, 2012, Acta neuropathologica, 124, 615, 10.1007/s00401-012-1031-3 · DOI · Paper page
  33. Kannan, 2012, 3, 1194, 10.18632/oncotarget.689 · DOI · Paper page
  34. Hartmann, 2010, Acta neuropathologica, 120, 707, 10.1007/s00401-010-0781-z · DOI · Paper page
  35. 2013, Acta neuropathologica, 126, 277, 10.1007/s00401-013-1130-9 · DOI
  36. 2009, Journal of Clinical Oncology, 27, 5874, 10.1200/JCO.2009.23.6497 · DOI · Paper page
  37. Esteller, 2000, New England Journal of Medicine, 343, 1350, 10.1056/NEJM200011093431901 · DOI · Paper page
  38. Hegi, 2005, New England Journal of Medicine, 352, 997, 10.1056/NEJMoa043331 · DOI · Paper page
  39. 2013, Archives of medical research, 44, 281, 10.1016/j.arcmed.2013.04.004 · DOI
  40. Sadones, 2009, European journal of cancer (Oxford, England : 1990), 45, 146, 10.1016/j.ejca.2008.09.002 · DOI
  41. 2011, Clinical Cancer Research, 17, 7148, 10.1158/1078-0432.CCR-11-1274 · DOI
  42. 2013, PNAS, 110, 6021, 10.1073/pnas.1303607110 · DOI · Paper page
  43. 2013, Acta neuropathologica, 126, 267, 10.1007/s00401-013-1141-6 · DOI · Paper page
  44. 2013, Acta neuropathologica, 126, 443, 10.1007/s00401-013-1156-z · DOI · Paper page
  45. 2011, Cancer Research, 71, 7568, 10.1158/0008-5472.CAN-11-0013 · DOI
  46. 2012, Cancer Epidemiology Biomarkers & Prevention, 21, 2242, 10.1158/1055-9965.EPI-12-0703 · DOI
  47. 2012, Cancer genetics and cytogenetics, 205, 613, 10.1016/j.cancergen.2012.10.009 · DOI · Paper page
  48. de Andrade, 2001, Genetic epidemiology, 20, 258, 10.1002/1098-2272(200102)20:2<258::AID-GEPI8>3.0.CO;2-N · DOI
  49. Felini, 2007, Neuroepidemiology, 29, 55, 10.1159/000108919 · DOI
  50. 2007, Carcinogenesis, 28, 1906, 10.1093/carcin/bgm073 · DOI
  51. Bethke, 2008, Cancer Epidemiology Biomarkers & Prevention, 17, 1195, 10.1158/1055-9965.EPI-07-2733 · DOI
  52. 2013, Genetic epidemiology, 37, 222, 10.1002/gepi.21707 · DOI
  53. Wrensch, 2009, Nature genetics, 41, 905, 10.1038/ng.408 · DOI · Paper page
  54. Shete, 2009, Nature genetics, 41, 899, 10.1038/ng.407 · DOI · Paper page
  55. 2011, Human Molecular Genetics, 20, 2897, 10.1093/hmg/ddr192 · DOI
  56. Stacey, 2011, Nature genetics, 43, 1098, 10.1038/ng.926 · DOI · Paper page
  57. Rajaraman, 2012, Human genetics, 131, 1877, 10.1007/s00439-012-1212-0 · DOI
  58. Jenkins, 2011, 204, 13, 10.1016/j.cancergencyto.2010.10.002 · DOI
  59. 2013, Neuro-Oncology, 15, 542, 10.1093/neuonc/nos284 · DOI
  60. Jenkins, 2012, Nature genetics, 44, 1122, 10.1038/ng.2388 · DOI
  61. 2013, Human Molecular Genetics, 22, 2293, 10.1093/hmg/ddt063 · DOI
  62. 2013, Neuro-Oncology, 15, 535, 10.1093/neuonc/nos324 · DOI
  63. 2013, British Journal of Cancer, 108, 2178, 10.1038/bjc.2013.155 · DOI
  64. 2012, Journal of Medical Genetics, 49, 420, 10.1136/jmedgenet-2012-100941 · DOI
  65. 2011, American Journal of Epidemiology, 173, 915, 10.1093/aje/kwq457 · DOI
  66. 2012, JNCI Journal of the National Cancer Institute, 104, 840, 10.1093/jnci/djs222 · DOI
  67. 2013, Neuro-Oncology, 15, 1041, 10.1093/neuonc/not051 · DOI
  68. Berg-Beckhoff, 2009, European journal of epidemiology, 24, 433, 10.1007/s10654-009-9355-6 · DOI
  69. 2009, Cancer Epidemiology Biomarkers & Prevention, 18, 1232, 10.1158/1055-9965.EPI-08-0995 · DOI
  70. McCarthy, 2011, Cancer Epidemiology Biomarkers & Prevention, 20, 370, 10.1158/1055-9965.EPI-10-0948 · DOI
  71. Scheurer, 2008, Cancer Epidemiology Biomarkers & Prevention, 17, 1277, 10.1158/1055-9965.EPI-07-2621 · DOI
  72. Schoemaker, 2006, International journal of cancer. Journal international du cancer, 119, 2165, 10.1002/ijc.22091 · DOI
  73. 2013, Cancer causes & control : CCC, 24, 949, 10.1007/s10552-013-0171-7 · DOI
  74. Wiemels, 2009, International journal of cancer. Journal international du cancer, 125, 680, 10.1002/ijc.24369 · DOI
  75. 2007, American Journal of Epidemiology, 166, 941, 10.1093/aje/kwm203 · DOI
  76. 2007, JNCI Journal of the National Cancer Institute, 99, 1544, 10.1093/jnci/djm170 · DOI · Paper page
  77. 2011, Neuro-Oncology, 13, 242, 10.1093/neuonc/noq173 · DOI
  78. 2013, Cancer Epidemiology Biomarkers & Prevention, 37, 908
  79. Scheurer, 2011, International journal of cancer. Journal international du cancer, 129, 2290, 10.1002/ijc.25883 · DOI
  80. Wiemels, 2007, Cancer Epidemiology Biomarkers & Prevention, 16, 1229, 10.1158/1055-9965.EPI-07-0041 · DOI
  81. 2011, JNCI Journal of the National Cancer Institute, 103, 1588, 10.1093/jnci/djr361 · DOI
  82. Schlehofer, 2011, Allergy, 66, 1434, 10.1111/j.1398-9995.2011.02670.x · DOI
  83. 2012, JNCI Journal of the National Cancer Institute, 104, 1251, 10.1093/jnci/djs315 · DOI
  84. 2010, Neuro-Oncology, 12, 444, 10.1093/neuonc/nop057 · DOI
  85. 2013, Journal of neuro-oncology, 113, 229, 10.1007/s11060-013-1122-6 · DOI
  86. 2007, Carcinogenesis, 28, 2543, 10.1093/carcin/bgm210 · DOI
  87. 2011, Frontiers in bioscience : a journal and virtual library, 3, 33, 10.2741/e217 · DOI
  88. 2013, Cancer Epidemiology Biomarkers & Prevention, 37, 306
  89. 2011, American Journal of Epidemiology, 174, 574, 10.1093/aje/kwr124 · DOI
  90. 2014, International journal of cancer. Journal international du cancer, 134, 2199, 10.1002/ijc.28535 · DOI
  91. 2010, Carcinogenesis, 31, 1770, 10.1093/carcin/bgq152 · DOI
  92. Turner, 2012, Cancer immunology, immunotherapy : CII, 61, 1493, 10.1007/s00262-011-1180-6 · DOI
  93. 2010, Neuro-Oncology, 12, 320, 10.1093/neuonc/nop035 · DOI
  94. Komohara, 2012, Cancer Science, 103, 2165, 10.1111/cas.12015 · DOI
  95. Bondy, 2008, Cancer, 113, 1953, 10.1002/cncr.23741 · DOI · Paper page
  96. Sadetzki, 2005, Radiation research, 163, 424, 10.1667/RR3329 · DOI
  97. Preston, 2007, Radiation research, 168, 1, 10.1667/RR0763.1 · DOI · Paper page
  98. Neglia, 2006, JNCI Journal of the National Cancer Institute, 98, 1528, 10.1093/jnci/djj411 · DOI · Paper page
  99. 2010, Journal of Clinical Oncology, 28, 5287, 10.1200/JCO.2009.27.0090 · DOI
  100. Davis, 2011, Radiation research, 175, 790, 10.1667/RR2186.1 · DOI
  101. Preston-Martin, 1989, Cancer Research, 49, 6137
  102. 2012, CA: A Cancer Journal for Clinicians, 62, 75, 10.3322/caac.21132 · DOI · Paper page
  103. Pearce, 2012, Lancet, 380, 499, 10.1016/S0140-6736(12)60815-0 · DOI · Paper page
  104. Picano, 2012, BMC cancer [electronic resource], 12, 157, 10.1186/1471-2407-12-157 · DOI
  105. Baan, 2011, The lancet oncology, 12, 624, 10.1016/S1470-2045(11)70147-4 · DOI · Paper page
  106. 2011, BMJ, 343, d6387, 10.1136/bmj.d6387 · DOI
  107. 2013, International Journal of Epidemiology, 42, 792, 10.1093/ije/dyt072 · DOI
  108. 2013, International journal of oncology, 43, 1833, 10.3892/ijo.2013.2111 · DOI
  109. 2014, International Journal of Epidemiology, 43, 275, 10.1093/ije/dyt186 · DOI
  110. 1987, JNCI Journal of the National Cancer Institute, 78, 253, 10.1093/jnci/78.2.253 · DOI
  111. T rnqvist, 1991, British Journal of Industrial Medicine, 48, 597
  112. Tynes, 1992, American Journal of Epidemiology, 136, 81, 10.1093/oxfordjournals.aje.a116423 · DOI
  113. Hakansson, 2002, Occupational and Environmental Medicine, 59, 481, 10.1136/oem.59.7.481 · DOI
  114. 2007, Occupational and Environmental Medicine, 64, 782, 10.1136/oem.2006.029116 · DOI
  115. 2007, Occupational and Environmental Medicine, 64, 553, 10.1136/oem.2006.030270 · DOI
  116. Floderus, 1993, Cancer causes & control : CCC, 4, 465, 10.1007/BF00050866 · DOI
  117. Karipidis, 2007, Cancer causes & control : CCC, 18, 305, 10.1007/s10552-006-0106-7 · DOI
  118. 2007, Occupational Medicine, 57, 518, 10.1093/occmed/kqm078 · DOI
  119. Villeneuve, 2002, International Journal of Epidemiology, 31, 210, 10.1093/ije/31.1.210 · DOI
  120. Kheifets, 2008, Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine, 50, 677, 10.1097/JOM.0b013e3181757a27 · DOI
  121. 2014, Cancer causes & control : CCC, 25, 203, 10.1007/s10552-013-0322-x · DOI
  122. 2009, Neuro-Oncology, 11, 242, 10.1215/15228517-2009-002 · DOI
  123. Baldi, 2011, International journal of cancer. Journal international du cancer, 129, 1477, 10.1002/ijc.25765 · DOI
  124. Feychting, 1997, Epidemiology (Cambridge, Mass.), 8, 384, 10.1097/00001648-199707000-00006 · DOI
  125. Savitz, 2000, American journal of industrial medicine, 38, 417, 10.1002/1097-0274(200010)38:4<417::AID-AJIM7>3.0.CO;2-W · DOI
  126. Sorahan, 2001, Occupational and Environmental Medicine, 58, 626, 10.1136/oem.58.10.626 · DOI
  127. Theriault, 1994, American Journal of Epidemiology, 139, 550, 10.1093/oxfordjournals.aje.a117046 · DOI
  128. Navas-Acien, 2002, Cancer Epidemiology Biomarkers & Prevention, 11, 1678
  129. Ohgaki, 2009, Methods in molecular biology (Clifton, N.J.), 472, 323, 10.1007/978-1-60327-492-0_14 · DOI · Paper page
  130. Pukkala, 2009, Acta oncologica (Stockholm, Sweden), 48, 646, 10.1080/02841860902913546 · DOI · Paper page
  131. Zheng, 2001, Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine, 43, 317, 10.1097/00043764-200104000-00005 · DOI
  132. De Roos, 2003, Cancer causes & control : CCC, 14, 139, 10.1023/A:1023053916689 · DOI
  133. Khuder, 1998, American journal of industrial medicine, 34, 252, 10.1002/(SICI)1097-0274(199809)34:3<252::AID-AJIM7>3.0.CO;2-X · DOI
  134. Ruder, 2012, American journal of industrial medicine, 55, 747, 10.1002/ajim.22085 · DOI
  135. Pan, 2005, Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine, 47, 704, 10.1097/01.jom.0000165747.95801.c5 · DOI
  136. 2008, American Journal of Epidemiology, 167, 976, 10.1093/aje/kwm401 · DOI
  137. Bucchi, 2004, Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine, 46, 249, 10.1097/01.jom.0000116804.10496.fc · DOI
  138. M n goz, 2002, European journal of cancer (Oxford, England : 1990), 38, 696, 10.1016/S0959-8049(01)00423-3 · DOI
  139. Viel, 1998, Archives of Environmental Health, 53, 65, 10.1080/00039899809605690 · DOI
  140. 2007, Occupational and Environmental Medicine, 64, 509, 10.1136/oem.2006.028100 · DOI
  141. 2013, Occupational and Environmental Medicine, 70, 73, 10.1136/oemed-2011-100588 · DOI
  142. Arora, 2010, European journal of cancer (Oxford, England : 1990), 46, 1607, 10.1016/j.ejca.2010.02.007 · DOI
  143. Arrigo, 2012, Journal of neuro-oncology, 106, 627, 10.1007/s11060-011-0702-6 · DOI
  144. 2010, American Journal of Epidemiology, 171, 1165, 10.1093/aje/kwq075 · DOI
  145. Carre n, 2005, Environmental Health Perspectives, 113, 546, 10.1289/ehp.7456 · DOI
  146. Yiin, 2012, Environmental health : a global access science source [electronic resource], 11, 39, 10.1186/1476-069X-11-39 · DOI

Cited by

See all 2,220

Metadata

Authors
Ostrom, Q. T., Bauchet, L., Davis, F. G., Deltour, I., Fisher, J. L., Langer, C. E., Pekmezci, M., Schwartzbaum, J. A., Turner, M. C., Walsh, K. M., Wrensch, M. R., & Barnholtz-Sloan, J. S.
Venue
Neuro-Oncology
Publisher
Oxford University Press (OUP)
Published
2014-05-19
Volume
16
Issue
7
Pages
896-913
ISSN
  • 1522-8517 (ISSN-L)
  • 1523-5866
DOI
10.1093/neuonc/nou087
OpenAlex
W2135465849
Cited by
2,220
References
7
FWCI
42.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.